The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 19037576)

Published in Osteoporos Int on November 27, 2008

Authors

K Zhu1, J Beilby, I M Dick, A Devine, M Soós, R L Prince

Author Affiliations

1: School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.

Articles cited by this

Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02

A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet (1998) 4.96

Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med (2004) 4.34

Retracted Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA (2005) 4.12

Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med (2006) 4.09

Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr (2001) 3.80

Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1987) 3.58

Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med (2004) 3.32

The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Aust N Z J Public Health (2000) 3.01

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA (1995) 2.31

Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) Circulation (1999) 1.90

Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort. Asia Pac J Clin Nutr (1994) 1.80

Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone (2005) 1.69

Dietary fat and plasma total homocysteine concentrations in 2 adult age groups: the Hordaland Homocysteine Study. Am J Clin Nutr (2007) 1.55

Protein consumption is an important predictor of lower limb bone mass in elderly women. Am J Clin Nutr (2005) 1.52

Comparison of genome screens for two independent cohorts provides replication of suggestive linkage of bone mineral density to 3p21 and 1p36. Am J Hum Genet (2002) 1.51

Recreational physical activity levels in healthy older women: the importance of fear of falling. J Am Geriatr Soc (2002) 1.44

Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta (1996) 1.35

First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur J Hum Genet (1998) 1.32

Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res (2005) 1.27

Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem (2000) 1.13

The kidney and homocysteine metabolism. J Am Soc Nephrol (2001) 1.12

Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res (2007) 1.11

Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6. Seizure (2006) 1.01

Homocysteine and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int (2007) 0.94

Physical activity and calcium consumption are important determinants of lower limb bone mass in older women. J Bone Miner Res (2004) 0.94

Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Bone (2004) 0.94

Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J Bone Miner Res (2003) 0.92

Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Bone (2004) 0.92

A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res (2003) 0.90

Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone (2005) 0.89

Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels. Vasc Health Risk Manag (2007) 0.87

Randomized clinical trial of homocysteine level lowering therapy and fractures. Arch Intern Med (2007) 0.87

Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial. Am J Clin Nutr (2007) 0.85

The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study. Atherosclerosis (2001) 0.85

Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women. Clin Chem Lab Med (2005) 0.84

Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone (2003) 0.84

Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population. Am J Clin Nutr (1999) 0.84

The interaction between MTHFR 677 C-->T genotype and folate status is a determinant of coronary atherosclerosis risk. J Nutr (2003) 0.82

Association of a 31 bp VNTR in the CBS gene with postload homocysteine concentrations in the Framingham Offspring Study. Eur J Hum Genet (2006) 0.80

Precision error of fan-beam dual X-ray absorptiometry scans at the spine, hip, and forearm. J Clin Densitom (2000) 0.78

Effects of the interaction between the C677T 5,10-methylenetetrahydrofolate reductase polymorphism and serum B vitamins on homocysteine levels in pregnant women. Eur J Clin Nutr (2004) 0.77

Articles by these authors

Hypovitaminosis D in medical inpatients. N Engl J Med (1998) 9.13

Modelling in economic evaluation: an unavoidable fact of life. Health Econ (1997) 3.40

General practitioners and palliative care. Palliat Med (1993) 2.83

The calcium scare--what would Austin Bradford Hill have thought? Osteoporos Int (2011) 2.35

General practitioners' knowledge and use of living wills. BMJ (1995) 2.08

Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl J Med (1991) 2.05

Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro. Cancer Res (2001) 1.94

Comparison of genome screens for two independent cohorts provides replication of suggestive linkage of bone mineral density to 3p21 and 1p36. Am J Hum Genet (2002) 1.51

A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am J Clin Nutr (1995) 1.50

Nutritional effect of calcium supplementation by skim milk powder or calcium tablets on total nutrient intake in postmenopausal women. Am J Clin Nutr (1996) 1.49

South Australian hypertension survey. General practitioner knowledge and reported management practices--a cause for concern? Med J Aust (1992) 1.49

Risk factors for repeat attendance at hospital emergency departments among adults and children with asthma. Aust N Z J Med (1997) 1.48

Predictive gene testing for Huntington disease and other neurodegenerative disorders. Intern Med J (2013) 1.45

Instrument performance in bone density testing at five Australian centres. Aust N Z J Med (1997) 1.39

A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut (2002) 1.32

The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women. J Bone Miner Res (1995) 1.31

The national asthma audit. Bridging the gap between guidelines and practice. Aust Fam Physician (1998) 1.25

Longitudinal assessment of changes in reproductive hormones during normal pregnancy. Clin Chem (1991) 1.23

Depressive disorders and unprotected casual anal sex among Australian homosexually active men in primary care. HIV Med (2003) 1.20

Comparison of QCT-derived and DXA-derived areal bone mineral density and T scores. Osteoporos Int (2008) 1.20

A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int (1999) 1.18

LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone (2005) 1.11

Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene. Int J Cancer (1998) 1.10

Carcinoma of cervix with recent normal Papanicolaou tests. Lancet (1980) 1.10

An in vivo comparison of hip structure analysis (HSA) with measurements obtained by QCT. Osteoporos Int (2011) 1.07

No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. Bone (2006) 1.07

Exercise for depression in care home residents: a randomised controlled trial with cost-effectiveness analysis (OPERA). Health Technol Assess (2013) 1.05

Vitamin A and cancer prevention I: observations in workers previously exposed to asbestos at Wittenoom, Western Australia. Int J Cancer (1998) 1.04

Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study. Diabetologia (2006) 1.04

Effects of endogenous estrogen on renal calcium and phosphate handling in elderly women. Am J Physiol Endocrinol Metab (2004) 1.03

Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women. Am J Physiol Endocrinol Metab (2004) 1.03

Oxidative stress during acute respiratory exacerbations in cystic fibrosis. Thorax (1999) 1.03

The impact of nausea and vomiting on women: a burden of early pregnancy. Aust N Z J Obstet Gynaecol (2000) 1.03

Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes. Diabet Med (2009) 1.02

Pregnancy outcome following women's participation in a randomised controlled trial of acupuncture to treat nausea and vomiting in early pregnancy. Complement Ther Med (2002) 1.01

Special report on the official positions of the International Society for Clinical Densitometry. Osteoporos Int (2004) 1.00

The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects. Metabolism (1981) 0.99

A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone. Bone (2004) 0.99

Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in postmenopausal women. Osteoporos Int (2001) 0.99

Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rate in a large cohort of elderly women. Calcif Tissue Int (2003) 0.98

The management of metformin overdose. Anaesthesia (1998) 0.97

Predictors of low bone density in young adolescent females with anorexia nervosa and other dieting disorders. Int J Eat Disord (2001) 0.96

Effects of a 1-year randomized controlled trial of resistance training on lower limb bone and muscle structure and function in older men. Osteoporos Int (2010) 0.95

Antigen presentation by macrophages is enhanced by the uptake of necrotic, but not apoptotic, cells. Clin Exp Immunol (2002) 0.94

South Australian hypertension survey. General practitioner experiences with drug treatment. Med J Aust (1992) 0.94

Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables. Stat Med (2010) 0.93

Bone mass effects of a BMP4 gene polymorphism in postmenopausal women. Bone (2005) 0.93

In vitro growth inhibition of Plasmodium falciparum by retinol at concentrations present in normal human serum. Acta Trop (1998) 0.92

The effects of high potassium consumption on bone mineral density in a prospective cohort study of elderly postmenopausal women. Osteoporos Int (2008) 0.92

Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology (1999) 0.91

Homozygous deletion of the UGT2B17 gene is not associated with osteoporosis risk in elderly Caucasian women. Osteoporos Int (2010) 0.91

Prediction of incident osteoporotic fractures in elderly women using the free estradiol index. Osteoporos Int (2004) 0.90

A 4-year follow-up study of the effects of calcium supplementation on bone density in elderly postmenopausal women. Osteoporos Int (1997) 0.89

Klotho gene polymorphisms are associated with osteocalcin levels but not bone density of aged postmenopausal women. Calcif Tissue Int (2005) 0.89

Correlates of intestinal calcium absorption in women 10 years past the menopause. Calcif Tissue Int (1993) 0.89

Apolipoprotein E4 is associated with reduced calcaneal quantitative ultrasound measurements and bone mineral density in elderly women. Bone (2002) 0.89

Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administration. Clin Endocrinol (Oxf) (1995) 0.89

Knowledge of and reported asthma management among South Australian general practitioners. Br J Gen Pract (1994) 0.88

The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35 to 90. J Bone Miner Res (1995) 0.88

Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another. J Bone Miner Res (1999) 0.86

Adequacy and change in nutrient and food intakes with aging in a seven-year cohort study in elderly women. J Nutr Health Aging (2010) 0.86

Under-reporting of energy intake in elderly Australian women is associated with a higher body mass index. J Nutr Health Aging (2013) 0.86

A genome-wide association scan for asthma in a general Australian population. Hum Genet (2008) 0.85

Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. Nephron (1992) 0.85

Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies. Br J Cancer (2012) 0.84

The Teamwork Study: enhancing the role of non-GP staff in chronic disease management in general practice. Aust J Prim Health (2013) 0.84

Characterization of the effect of retinol on Plasmodium falciparum in vitro. Exp Parasitol (2004) 0.84

Iritis following intravenous pamidronate. Aust N Z J Med (1996) 0.83

The T869C TGF beta polymorphism is associated with fracture, bone mineral density, and calcaneal quantitative ultrasound in elderly women. Bone (2003) 0.83

Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study. Bone (1996) 0.83

Effect of creatine loading on long-term sprint exercise performance and metabolism. Med Sci Sports Exerc (2001) 0.83

Differences in structural geometrical outcomes at the neck of the proximal femur using two-dimensional DXA-derived projection (APEX) and three-dimensional QCT-derived (BIT QCT) techniques. Osteoporos Int (2011) 0.83

Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium. J Bone Miner Res (1993) 0.83

Spontaneous hip fractures in fluoride-treated patients: potential causative factors. J Bone Miner Res (1990) 0.82

Biochemical and ultrastructural indices of muscle damage after a twenty-one kilometre run. Aust J Sci Med Sport (1997) 0.82

Localization of a non-melanoma skin cancer susceptibility region within the major histocompatibility complex by association analysis using microsatellite markers. Tissue Antigens (2003) 0.82